These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 28758270)

  • 21. Maternal use of thyroid hormone replacement therapy before, during, and after pregnancy: agreement between self-report and prescription records and group-based trajectory modeling of prescription patterns.
    Frank AS; Lupattelli A; Matteson DS; Nordeng H
    Clin Epidemiol; 2018; 10():1801-1816. PubMed ID: 30584374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.
    Blotière PO; Weill A; Dalichampt M; Billionnet C; Mezzarobba M; Raguideau F; Dray-Spira R; Zureik M; Coste J; Alla F
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):763-770. PubMed ID: 29763992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study.
    Louchet M; Collier M; Beeker N; Mandelbrot L; Sibiude J; Chouchana L; Treluyer JM
    PLoS One; 2024; 19(1):e0295897. PubMed ID: 38198446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database.
    Araujo M; Hurault-Delarue C; Sommet A; Damase-Michel C; Benevent J; Lacroix I
    Therapie; 2021; 76(3):239-247. PubMed ID: 32736872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
    Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015.
    Engeland A; Bjørge T; Klungsøyr K; Hjellvik V; Skurtveit S; Furu K
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):995-1004. PubMed ID: 29920833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription drug use in pregnancy and variations according to prior psychiatric history.
    Ingstrup KG; Liu X; Gasse C; Debost JP; Munk-Olsen T
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):105-113. PubMed ID: 29171114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teratogenic mechanisms of medical drugs.
    van Gelder MM; van Rooij IA; Miller RK; Zielhuis GA; de Jong-van den Berg LT; Roeleveld N
    Hum Reprod Update; 2010; 16(4):378-94. PubMed ID: 20061329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcome of pregnancy in patients exposed in utero to diethylstilbestrol. Survey by the National College of French Gynecologists and Obstetricians].
    Pons JC; Goujard J; Derbanne C; Tournaire M
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):307-16. PubMed ID: 3294279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of Medication in Pregnancy.
    Dathe K; Schaefer C
    Dtsch Arztebl Int; 2019 Nov; 116(46):783-790. PubMed ID: 31920194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription drug use during pregnancy in developed countries: a systematic review.
    Daw JR; Hanley GE; Greyson DL; Morgan SG
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):895-902. PubMed ID: 21774029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.
    Demailly R; Escolano S; Quantin C; Tubert-Bitter P; Ahmed I
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1126-1134. PubMed ID: 28758270
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.